<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Resistance of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) to the available chemotherapy reveals the demand for identification of new anticancer agents </plain></SENT>
<SENT sid="1" pm="."><plain>We evaluated the antitumour potential of altholactone, a naturally occurring bioactive compound isolated from Goniothalamus spp </plain></SENT>
<SENT sid="2" pm="."><plain>(Annonaceae) hooks, against <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells </plain></SENT>
<SENT sid="3" pm="."><plain>Antitumour activity of altholactone was measured using <z:chebi fb="0" ids="53233">3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide</z:chebi> assay and the <z:chebi fb="0" ids="51240">propidium iodide</z:chebi> method </plain></SENT>
<SENT sid="4" pm="."><plain><z:mpath ids='MPATH_3'>Apoptosis</z:mpath> mediators involved were assessed using biochemical inhibitors and Western blotting analysis </plain></SENT>
<SENT sid="5" pm="."><plain>Results revealed that altholactone induced varying degrees of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells but not in <z:mpath ids='MPATH_458'>normal</z:mpath> fibroblasts </plain></SENT>
<SENT sid="6" pm="."><plain>Dissection of the altholactone-induced apoptotic signalling pathway revealed that altholactone activated caspase-dependent and -independent apoptotic pathways </plain></SENT>
<SENT sid="7" pm="."><plain>Activation of caspase-4 appeared to be the initiating event in the caspase-dependent apoptotic pathway </plain></SENT>
<SENT sid="8" pm="."><plain>Pre-treatment of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells with the <z:chebi fb="11" ids="22586">antioxidant</z:chebi> <z:chebi fb="0" ids="28939">N-acetylcysteine</z:chebi> (NAC) significantly inhibited activation of caspase-4 and altholactone-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="9" pm="."><plain>These results indicate that altholactone induces selective cytotoxicity against colon <z:mp ids='MP_0002038'>carcinoma</z:mp> cells and warrants further clinical evaluation </plain></SENT>
</text></document>